SARS-CoV-2: Impact on, Risk Assessment and Countermeasures in German Eye Banks

References

• World Health Organization. WHO director-general’s opening remarks at the mission briefing on COVID-19. 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19—28-may–2020
   Google Scholar
• Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: Maier HJ, Bickerton E, Britton P editors. Coronaviruses. Vol. 1282. New York:Springer New York; 2015. 1–23. Methods in Molecular Biology. doi:10.1007/978-1-4939-2438-7_1
   Google Scholar
• Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Sci. 2020;367(6485):1444–48. doi:10.1126/science.abb2762.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Pöhlmann SA. Multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. M Cell. 2020;78(4):779–784.e5. doi:10.1016/j.molcel.2020.04.022.
   PubMed Web of Science ®Google Scholar
• Lang J, Yang N, Deng J, Liu K, Yang P, Zhang G, Jiang C. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans geraghty RJ, editor. PLoS ONE. 2011;6(8):e23710. doi:10.1371/journal.pone.0023710.
   PubMed Web of Science ®Google Scholar
• Sadhu S, Agrawal R, Pyare R, Pavesio C, Zierhut M, Khatri A, Smith JR, de Smet MD, Biswas J. COVID-19: limiting the risks for eye care professionals. Ocul Immunol Inflamm. 2020:1–7. doi:10.1080/09273948.2020.1755442.
   PubMed Web of Science ®Google Scholar
• Yu A-Y, Tu R, Shao X, Pan A, Zhou K, Huang J. A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology. Eye Vision. 2020;7(1):19. doi:10.1186/s40662-020-00187-2.
   Web of Science ®Google Scholar
• Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, Nicastri E, Bevilacqua N, Giancola ML, Corpolongo A, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann InternMed. 2020;2019(April):2019–21. doi:10.7326/m20-1176.
   Google Scholar
• Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, Lye DC, Agrawal R. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020;2019:2019–21. doi:10.1016/j.ophtha.2020.03.026.
   Google Scholar
• Desautels JD, Moshirfar M, Martheswaran T, Shmunes KM, Ronquillo YC. Risks posed to corneal transplant recipients by COVID-19-affected donors. Ophthalmol Ther. May 6 2020. doi: 10.1007/s40123-020-00254-w
   Web of Science ®Google Scholar
• Paul-Ehrlich-Institut. SARS-CoV-2: wie sicher sind Gewebezubereitungen? https://www.pei.de/DE/newsroom/dossier/coronavirus/coronavirus-inhalt.html
   Google Scholar
• Global Alliance of Eye Bank Associations. Coronavirus (COVID-2019) and ocular tissue donation. 2020. http://www.gaeba.org/wp-content/uploads/2020/03/GAEBA-COVID19-Alert-25-March-2020.pdf
   Google Scholar
• European Centre for Disease Prevention and Control. Coronavirus disease - 2019 (COVID-19) and supply of substances of human origin in EU/EEA - first update. 2020. https://www.ecdc.europa.eu/sites/default/files/documents/COVID%2019-supply-substances-human-origin-first-update.pdf
   Google Scholar
• Zitek T. The appropriate use of Testing for COVID-19. West J Emerg Med. 2020 Jun 4;21(3). https://escholarship.org/uc/item/1gh0z5t0
   Web of Science ®Google Scholar
• Deng C, Yang Y, Chen H, Chen W, Chen Z, Ma K, Wang J. Ocular detection of SARS-CoV-2 in 114 cases of COVID-19 pneumonia in Wuhan, China: an observational study. SSRN Electron J. 2020 Jun 1. https://www.ssrn.com/abstract=3543587
   Google Scholar
• Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, Xin N, Huang Z, Liu L, Zhang G, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Brit J Ophthalmol. 2020;(figure 2):1–4. doi:10.1136/bjophthalmol-2020-316304.
   PubMedGoogle Scholar
• Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532(1–2):107–10. doi:10.1016/S0014-5793(02)03640-2.
   PubMed Web of Science ®Google Scholar
• Lange C, Wolf J, Auw‐Haedrich C, Schlecht A, Boneva S, Lapp T, Horres R, Agostini H, Martin G, Reinhard T et al. Expression of the COVID‐19 receptor ACE2 in the human conjunctiva. J Med Virol. 2020 May;6(jmv):25981. doi:10.1002/jmv.25981.
   Google Scholar
• Lin L, Yan S, Xin P. Expression of SARS coronavirus S protein functional receptor-angiotensin-converting enzyme 2 in human cornea and conjunctiva. Chin Ophthalmic Res. 2004;22:561–64.
   Google Scholar
• Sun Y, Pan X. Mechanisms of the action between the SARS-Cov S440 protein and the ACE2 receptor in eyes. Int J Ophthalmol. 2006;6:783–86.
   Google Scholar
• HCA Lung Biological Network; Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681–87. doi:10.1038/s41591-020-0868-6.
   PubMed Web of Science ®Google Scholar
• Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Pathology. 2020. doi:10.1101/2020.05.09.086165.
   PubMedGoogle Scholar
• Ma D, Chen C-B, Jhanji V, Xu C, Yuan X-L, Liang -J-J, Huang Y, Cen L-P, Ng TK. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye. 2020;34(7):1212–19. doi:10.1038/s41433-020-0939-4.
   PubMed Web of Science ®Google Scholar
• European Directorate for the Quality of Medicines & Healthcare. Guide to the quality and safety of tissues and cells for human application. 4th edition ed. Strasbourg, France: EDQM, Counsil of Europe; 2019.
   Google Scholar
• Bunyan D, Ritchie L, Jenkins D, Coia JE. Respiratory and facial protection: a critical review of recent literature. J Hosp Infect. 2013;85(3):165–69. doi:10.1016/j.jhin.2013.07.011.
   PubMed Web of Science ®Google Scholar
• Lindsley WG, Noti JD, Blachere FM, Szalajda JV, Beezhold DH. Efficacy of face shields against cough aerosol droplets from a cough simulator. J Occup Environ Hyg. 2014;11(8):509–18. doi:10.1080/15459624.2013.877591.
   PubMed Web of Science ®Google Scholar
• Garcia Godoy LR, Jones AE, Anderson TN, Fisher CL, Seeley KML, Beeson EA, Zane HK, Peterson JW, Sullivan PD. Facial protection for healthcare workers during pandemics: a scoping review. BMJ Global Health. 2020;5(5):e002553. doi:10.1136/bmjgh-2020-002553.
   PubMed Web of Science ®Google Scholar
• Lee S-A, Grinshpun SA, Reponen T. Respiratory performance offered by N95 respirators and surgical masks: human subject evaluation with NaCl aerosol representing bacterial and viral particle size range. Ann Occup Hyg. 2008;52(3):177–85. doi:10.1093/annhyg/men005.
   PubMed Web of Science ®Google Scholar
• Ng K, Poon BH, Kiat Puar TH, Shan Quah JL, Loh WJ, Wong YJ, Tan TY, Raghuram J. COVID-19 and the risk to health care workers: a case report. Ann Intern Med. 2020 Mar;16:L20–0175. doi:10.7326/L20-0175.
   Google Scholar
• Radonovich LJ, Simberkoff MS, Bessesen MT, Brown AC, Cummings DAT, Gaydos CA, Los JG, Krosche AE, Gibert CL, Gorse GJ, et al. N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. JAMA. 2019;322(9):824. doi:10.1001/jama.2019.11645.
   PubMed Web of Science ®Google Scholar
• Smith JD, MacDougall CC, Johnstone J, Copes RA, Schwartz B, Garber GE. Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis. Can Med Assoc J. 2016;188(8):567–74. doi:10.1503/cmaj.150835.
   PubMed Web of Science ®Google Scholar